CLSA Capital backs ACT Genomics
Taiwan-based ACT Genomics Holdings Company Limited, an Asia-based DNA sequencing-based cancer solution provider, has raised an undisclosed amount of funding. The investors included CLSA Capital Partners.
26 September 2018•1 min read
